Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07YPP
|
|||
| Former ID |
DIB011719
|
|||
| Drug Name |
BreMel/TNF alpha
|
|||
| Synonyms |
BreMel/TNF alpha (melanoma/lobular breast cancer); Aka scFvMel/TNF (melanoma/lobular breast cancer), Targa Therapeutics; BreMel/TNF alpha (melanoma/ breast cancer), Targa Therapeutics; BreMel/TNF alpha (melanoma/lobular breast cancer), Targa Therapeutics; ScFvMel/TNF alpha (melanoma/ breast cancer), Targa Therapeutics; BreMel/TNF-a (melanoma/lobular breast cancer), Targa Therapeutics; ScFvMel/TNF-a (melanoma/lobular breast cancer), Targa Therapeutics; ZME-018 antibody fragment/TNF alpha (melanoma/ breast cancer), Targa Therapeutics
Click to Show/Hide
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Investigative | [1] | |
| Company |
Targa Therapeutics Corp
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.